SCHEMBL6330652

SCHEMBL6330652

CC(C)CC(O)CCCNC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
KISS1R Q969F8 3/20 0.41
ANPEP P15144 3/20 0.39
DNPEP Q9ULA0 2/20 0.39
CACNA1B Q00975 2/20 0.38
RNPEP Q9H4A4 3/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
MMP8 P22894 2/20 0.36
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21199399 0.88 CYP2D6 (0.46) CYP2D6CYP2C19KISS1RANPEPDNPEP
SCHEMBL6720432 0.81 CYP2D6 (0.52) CYP2D6CYP2C19KISS1RANPEPDNPEP
SCHEMBL3856822 0.80 GPR84 (0.38) CYP2D6CYP2C19MEN1GAAKMT2A
SCHEMBL2846868 0.79 ALDH1A1 (0.48) CYP2D6CYP2C19KISS1RMEN1GAA
SCHEMBL6330673 0.78 FFAR4 (0.48)
SCHEMBL6079300 0.78 FFAR4 (0.44) HDAC1HDAC2MEN1GAAKMT2A
SCHEMBL25542569 0.78 MMP8 (0.44) CYP2D6CYP2C19KISS1RANPEPDNPEP
SCHEMBL3772713 0.78 THRB (0.39) CYP2D6CYP2C19MEN1GAAKMT2A
SCHEMBL18969592 0.78 EPHX1 (0.63) MMP8
SCHEMBL10141101 0.75 CYP2D6 (0.50) CYP2D6CYP2C19MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6900243-B2 Phenylheteroalkylamine derivatives ASTRAZENECA AB (SE) 2005-05-31 US disclosed
EP-1263715-B1 NOVEL PHENYLHETEROALKYLAMINE DERIVATIVES ASTRAZENECA AB (SE) 2004-04-28 EP disclosed
US-20030065174-A1 Novel phenylheteroalkylamine derivatives ASTRAZENECA AB (SE) 2003-04-03 US disclosed
EP-1263715-A1 NOVEL PHENYLHETEROALKYLAMINE DERIVATIVES AstraZeneca AB (SE) 2002-12-11 EP disclosed
WO-2001062714-A1 NOVEL PHENYLHETEROALKYLAMINE DERIVATIVES ASTRAZENECA AB (SE) 2001-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065174-A1 Novel phenylheteroalkylamine derivatives OPRK1, NOS2, OPRM1 CYP2D6 59/4885CYP2C19 88/4885KISS1R 4018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.